Trial
NCT04263519
A Pilot Open Labeled Study of Tacrolimus in Alzheimer's Disease.
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Massachusetts General Hospital
Collaborators
—
Condition
Alzheimer Disease
Intervention
Tacrolimus
Why stopped
Covid restrictions
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-09-27